Pezzolo E, Mariateresa R, Luyo Saboya RA, Malagoli P, Narcisi A, Ferrucci SM, et al. Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis). Acta Derm Venereol [Internet]. 2026 Apr. 14 [cited 2026 Apr. 27];106:adv-2025. Available from: https://medicaljournalssweden.se/actadv/article/view/45927